During the BIO International Convention in Boston, Massachusetts, King Faisal Specialist Hospital & Research Center (KFSHRC) and Germfree Laboratories announced a strategic partnership to develop ...

South Korean contract development and manufacturing organization (CDMO) Lotte Biologics signed an agreement with Ottimo Pharma, a biotechnology company that emerged from stealth less than a year ago.

Following a successful pilot episode filmed at Phacilitate’s January 2025 Advanced Therapies Week, AT3 announced last week that it will broadcast six video panel discussions on continuing questions in ...

Biopharma firm Sanofi is preparing millions of doses of its Beyfortus (nirsevimab) monoclonal antibody, shipping them starting in early Q3 to ensure broad availability ahead of the 2025-2026 ...

Ingress of carbon dioxide into bulk drug substance (BDS) containers that are stored and shipped on dry ice is a serious and often understated problem. Bottles are a container of choice for freezing ...

Figure 1: (a) Cell and gene therapy development pathway from patient/donor (red) to recipient (blue); (b) subcellular molecules and ions important for effective cell and gene therapy cultures ...

In a talk at the 46th Annual Goldman Sachs Global Healthcare Conference in Miami, Florida, executives from Regeneron discussed how the company is responding to a recent flurry of complete response ...

Biomanufacturing company Axio BioPharma and drug delivery firm Likarda have partnered to accelerate drug development and manufacturing. The collaboration will integrate Likarda’s delivery technologies ...

This webcast features: Aleš Štrancar, Managing Director, BIA Separations, a Sartorius Company In vitro transcription (IVT), the enzymatic process used for the production of mRNA vaccines, ...

Cell and gene therapies have reached clinical and commercial success as evidenced by the steady number of first approvals over the past four years. Drug developers face mounting challenges linked to ...

As gene therapies continue to stake their foothold on the clinical trial landscape and comprise the future wave of lifesaving pharmaceuticals, high-quality GMP-grade plasmids are increasingly in ...

Vaccines have been protecting against disease since the late 1700s. They function by triggering the immune system to generate short-term and long-term responses. Because there are many pathogens, ...